Literature DB >> 4673791

Differential immune response to attenuated rubella virus vaccine.

J D Gupta, V J Peterson, A M Murphy.   

Abstract

Serum samples collected from 18 volunteers 1, 2, and 3 months after vaccination with Cendehill strain of attenuated rubella virus vaccine were fractionated on a Sephadex G-200 column to test for immunoglobulin M (IgM) antibody. Seventeen of the 18 had demonstrable IgM antibody in serum collected 1 month postvaccination whereas only 5 and 3 had IgM antibody 2 and 3 months, respectively, post-inoculation. The geometric mean titers of hemagglutination-inhibiting antibody in the 19S fraction were 38, 7, and 6 at 1, 2, and 3 months after vaccination, whereas the corresponding 7S titers were 29, 53, and 57, respectively. Four other seronegative volunteers vaccinated with Cendevax were tested serially for total antibody only in whole blood obtained by finger pricks. Three of them showed appearance of antibody between 14 and 17 days and one between 17 and 21 days. It appears that vaccine-induced immune response is similar to natural infection especially with regard to the time of appearance of antibody and the relative proportions of IgM and IgG antibody thus produced.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4673791      PMCID: PMC422338          DOI: 10.1128/iai.5.2.151-154.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Fluorescent-antibody marker for vaccine-induced rubella antibodies.

Authors:  G C Brown; T P O'leary
Journal:  Infect Immun       Date:  1970-10       Impact factor: 3.441

2.  Serum IgM and IgG responses in postnatally acquired rubella.

Authors:  J M Best; J E Banatvala; D Watson
Journal:  Lancet       Date:  1969-07-12       Impact factor: 79.321

3.  Complement-fixing and fluorescent antibody responses to an attenuated Rubella virus vaccine.

Authors:  N J Schmidt; E H Lennette
Journal:  Am J Epidemiol       Date:  1970-04       Impact factor: 4.897

4.  Clinical trial of live attenuated rubella virus vaccine, HPV-77 strain.

Authors:  L Z Cooper; J P Giles; S Krugman
Journal:  Am J Dis Child       Date:  1968-06

5.  Determination of rubella hemagglutination-inhibiting antibody in whole blood.

Authors:  J D Gupta; V J Peterson; J D Harley
Journal:  Appl Microbiol       Date:  1971-11

6.  A study of rubella immunity and resistance to infection.

Authors:  W J Davis; H E Larson; J P Simsarian; P D Parkman; H M Meyer
Journal:  JAMA       Date:  1971-01-25       Impact factor: 56.272

7.  Rubella: reinfection of vaccinated and naturally immune persons exposed in an epidemic.

Authors:  D M Horstmann; H Liebhaber; G L Le Bouvier; D A Rosenberg; S B Halstead
Journal:  N Engl J Med       Date:  1970-10-08       Impact factor: 91.245

8.  Use of a new buffer system with formalinized sheep erythrocytes in the rubella hemagglutination-inhibition test.

Authors:  J D Gupta; V J Peterson
Journal:  Appl Microbiol       Date:  1971-04

9.  Immunoglobulin responses in rubella and its complications.

Authors:  M Haire; D S Hadden
Journal:  Br Med J       Date:  1970-07-18

10.  Single-sample diagnosis of recent rubella by fractionation of antibody on Sephadex G-200 column.

Authors:  J D Gupta; V Peterson; M Stout; A M Murphy
Journal:  J Clin Pathol       Date:  1971-09       Impact factor: 3.411

View more
  2 in total

1.  Specific immunoglobulin responses in serum and nasal secretions after the administration of attenuated rubella vaccine.

Authors:  J E Cradock-Watson; H Macdonald; M K Ridehalgh; M S Bourne; E M Vandervelde
Journal:  J Hyg (Lond)       Date:  1974-08

2.  A simplified method for the detection of rubella-specific IgM employing sucrose density fractionation and 2-mercaptoethanol.

Authors:  E O Caul; G W Smyth; S K Clarke
Journal:  J Hyg (Lond)       Date:  1974-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.